Akèy › Maladi fwa › Florid › Ocala
Etid klinik pou Maladi fwa nan Ocala, FL
3 etid pou Maladi fwa ap chèche patisipan nan sit nan ak bò kote Ocala (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Ap rekriteFaz 2
- Ocala GI Research, Ocala
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Ap rekriteFaz 3
- 89bio Clinical Study Site, Ocala
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Ap rekriteFaz 3
- 89bio Clinical Study Site, Ocala
Etid Maladi fwa nan lòt vil
- Houston, TX10 etid
- Chicago, IL9 etid
- Washington, DC8 etid
- Atlanta, GA7 etid
- Los Angeles, CA7 etid
- Richmond, VA6 etid
- New York City, NY6 etid
- San Antonio, TX6 etid
- Philadelphia, PA6 etid
- Dallas, TX5 etid
- Durham, NC5 etid
- Ann Arbor, MI5 etid
Lòt etid nan Ocala
- Kansè Poumon ki pa ti selil10 etid
- Maladi fwa steatotik8 etid
- Obèsite7 etid
- Maladi Alzheimer6 etid
- Sipwa6 etid
- BPCO5 etid
- Ensifizyans kadyak5 etid
- Fèbli Kognitif Lejè3 etid
- Kansè Metastatik3 etid
- Ateroskleroz3 etid
- Maladi kadyovaskilè3 etid
- Doulè kwonik3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.